Literature DB >> 312172

Human monocyte-lymphocyte interaction and its enhancement by levamisole.

J W Kazura, W Negendank, D Guerry, A D Schreiber.   

Abstract

We investigated the role of monocyte-lymphocyte interaction in the transformation of human peripheral blood lymphocytes by the mitogen concanavalin A (Con A). Human monocytes were separated from lymphocytes and were transiently exposed to Con A. The Con A-pretreated monocytes were able to subsequently bind autologus lymphocytes by a process that was selective for T cells. This interaction required the initial presence of Con A at the monocyte surface, and became independent of surface bound ligand after 72 hr. Levamisole, an agent thought to facilitate the participation of monocytes in the cellular immune response, enhanced the binding of lymphocytes to monocytes at low concentration of Con A (5--10 micrograms/ml). Levamisole did not lead to mitogen independent lymphocyte binding. The association between lymphocytes and Con A-pretreated monocytes resulted in the mitogenic transformation of lymphocytes in the absence of soluble Con A in the medium. These results suggest that, in addition to any possible soluble mediators, direct lymphocyte-monocyte contact is required for optimal mitogenic transformation. This T-cell-monocyte interaction over time becomes independent of cell-surface mitogen. The ability of levamisole to enhance this interaction may explain levamisole's capacity to stimulate lymphocyte proliferation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 312172      PMCID: PMC1537651     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

Review 1.  Levamisole in the modulation of the immune response: the current experimental and clinical state.

Authors:  J Symoens; M Rosenthal
Journal:  J Reticuloendothel Soc       Date:  1977-03

2.  Specific binding of T lymphocytes to macrophages. I. Kinetics of binding.

Authors:  M F Lipscomb; S Z Ben-Sasson; J W Uhr
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

3.  Effect of levamisole on the human monocyte IgG receptor.

Authors:  A D Schreiber; J N Parsons
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

4.  The effect of levamisole on human lymphocyte mediator production in vitro.

Authors:  M E Whitcomb; V J Merluzzi; S R Cooperband
Journal:  Cell Immunol       Date:  1976-02       Impact factor: 4.868

5.  The requirement for macrophage-lymphocyte interaction in T lymphocyte proliferation induced by generation of aldehydes on cell membranes.

Authors:  D K Greineder; A S Rosenthal
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

6.  Absolute macrophage dependency of T lymphocyte activation by mitogens.

Authors:  D L Rosenstreich; J J Farrar; S Dougherty
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

7.  Modulating effects of levamisole (NSC-177023) on human lymphocyte response in vitro.

Authors:  J L Lichtenfeld; M R Desner; P H Wiernik; M R Mardiney
Journal:  Cancer Treat Rep       Date:  1976-05

8.  In vitro stimulation of neutrophil motility by levamisole: maintenance of cgmp levels in chemotactically stimulated levamisole-treated neutrophils.

Authors:  R Anderson; A Glover; H J Koornhof; A R Rabson
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

9.  Concanavalin A-mediated binding and sphering of human red blood cells by homologous monocytes.

Authors:  D Guerry; M A Kenna; A D Schrieber; R A Cooper
Journal:  J Exp Med       Date:  1976-12-01       Impact factor: 14.307

10.  Macrophage-lymphocyte interaction. II. Antigen-mediated physical interactions between immune guinea pig lymph node lymphocytes and syngeneic macrophages.

Authors:  P E Lipsky; A S Rosenthal
Journal:  J Exp Med       Date:  1975-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.